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How Does the Main Infective 
Stage of T. cruzi Enter and Avoid 
Degradation in Host Cells? A 
Description of the Pathways and 
Organelles Involved on These 
Processes
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Abstract
Trypanosoma cruzi, the etiological agent of Chagas disease, is an intracellular 
parasite that targets specific proteins of the host cell resulting in the generation 
of a unique parasitophorous vacuole (PV). As an intracellular parasite, T. cruzi 
interacts with cells from the mammalian host. Here we review aspects related with 
the binding of the main infective developmental stage (trypomastigote) to the 
host cell and its recognition by surface-exposed ligands/receptors. This process 
involves numerous signaling pathways and culminates in the entry of the parasite 
and modifications in both cells. The invasion of trypomastigotes occurs through 
multiple endocytic process, assembly of the PV, interaction of this vacuole with the 
endolysosomal system, lysis of the PV membrane, and multiplication of amasti-
gotes within the cell in direct contact with host cell organelles.
Keywords: Trypanosoma cruzi, mammalian cells, host cell interaction,  
endocytic pathways, signaling, parasitophorous vacuole
1. Introduction
Trypanosoma cruzi, the etiological agent of Chagas disease, causes an anthropo-
zoonosis discovered and characterized by Dr. Carlos Chagas in 1909 [1] and recog-
nized by the World Health Organization (WHO) as one of the three most neglected 
tropical diseases of the world [2–4]. Nowadays, up to 8 million people are estimated 
to be infected with Chagas disease only in the Americas. Patients who do not receive 
treatment can develop severe cardiac debility and gastrointestinal organ dysfunc-
tion and may die, and 25 million are at risk of contracting the disease [3, 4]. Due to 
population migration and specific modes of transmission, Chagas disease is spread-
ing beyond its natural geographical boundaries and becoming a global problem [5]. 
Although the protozoan has three major developmental stages, only two are capable 
of infecting mammals (trypomastigotes and amastigotes), and the trypomastigote 
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Figure 1. 
Intracellular cycle of T. cruzi. (A) Attachment of the trypomastigote. (B) Internalization and recruitment and 
fusion of host cell lysosomes. (C) Parasitophorous vacuole is formed and lysosomal content is released.  
(D) Differentiation of trypomastigote to amastigotes. (E) Parasitophorous vacuole membrane disintegration. 
(F) Amastigote division into cytoplasm. (G) Differentiation of amastigotes into trypomastigotes. (H) 
Liberation of parasites into extracellular [12].
stage is the main T. cruzi vector [6]. Recent data indicate the existence of an infec-
tive epimastigote-like stage observed in axenic cultures as well as in the invertebrate 
host [7]. It is important to point out that before publication of this article, it was 
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assumed that replicating epimastigotes present in the insect gut are not infective to 
mammalian host. During the vector infection (caused by a hematophagous insect 
of the family Reduviidae), metacyclic trypomastigotes [8], which penetrate the 
vertebrate host (several mammals, including man), are released along with their 
excreta coming in contact with conjunctiva areas or through small lesions in the 
own site of the bite (favored by the itch caused after the insect’s bite). In turn, meta-
cyclic trypomastigotes are able to invade virtually all cell types in the vertebrate 
host, especially muscle cells, fibroblasts, and macrophages [6]. At this moment, the 
intracellular cycle of T. cruzi begins, where the firing of several signaling cascades 
culminates with the closure of the parasitophorous vacuole (PV) where the parasite 
is found [9, 10]. After the PV closure, the process of differentiation of the parasite 
from the trypomastigote stage to the amastigote stage begins. At the same time, 
fragmentation of the PV membrane takes place most probably due to the increased 
concentration of the Tc-Tox perforin-like protein produced by the parasite [11]. 
After the destruction of the vacuole, the parasite, in the process of differentiation, 
will be found in the cytoplasm of the host cell where it will initiate its multiplication 
and subsequent differentiation for trypomastigotes culminating in the rupture of 
the host cell (Figure 1) [13]. The whole process of formation of the parasitophorous 
vacuole until its rupture counts on the participation of several organelles of the host 
cell. Among these, the best characterized is the participation of host cell endosomes 
and lysosomes. It is the fusion of these organelles with the PV membrane that 
probably allows the increase or expansion of the PV. In addition, this process is 
also responsible for the generation of an acidic environment within the PV, which 
probably will potentiate the action of Tc-Tox and PV membrane fragmentation [13]. 
Wilkowsky and colleagues [14] have shown that early and late endosomes were 
critical for vacuole formation. In addition, other organelles responsible for the pro-
duction of proteins and energy (endoplasmic reticulum (ER), Golgi complex (GC), 
and mitochondria) have also been observed during the initial infection process [11]. 
In this chapter we will discuss the available data on the process of parasite-host cell 
recognition, triggering of the internalization process, and biogenesis of the PV. A 
better understanding of all the processes may identify new potential targets to block 
parasite invasion and may constitute alternative ways to treat Chagas disease.
2. T. cruzi trypomastigote-host cell recognition
The trypomastigote stage of T. cruzi has the ability to invade both professional 
phagocytic cells and nonprofessional phagocytic mammalian cells either in vitro or 
in vivo [15–17]. The kinetics of the T. cruzi’s intracellular cycle varies according to 
the strain, including time duration (Y strain, e.g., has an intracellular cycle that is 
completed between 5 and 7 days), since the initial interaction with trypomastigotes, 
triggering a signaling cascade that culminates with the formation and closure of the 
PV where the parasite will be located for some time [18].
In order for the interaction process and consequent internalization of the parasite 
to occur, there must be a recognition between molecules present on the surface of 
both cells. These processes are complex and involve several adhesion molecules 
(Figure 2), signaling events, and proteolytic activities [10, 19]. Some of these mol-
ecules have been identified as participants in the adhesion and invasion processes, 
such as gp35/50 [20], gp82 (whose expression varies according to the T. cruzi strain 
analyzed) [21], and gp90 [22]. Both gp82 and gp90 are the main metacyclic stage-
specific surface molecules and are extremely important to oral infection [21, 23]. 
However, while glycoprotein 90 is known as a negative modulator of metacyclic 
trypomastigote invasion [24, 25], gp82 binds to an unidentified receptor in host cell 
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surface mediating a calcium-dependent signaling pathway that will be discussed 
below [20, 26]. Although the receptors presented in host cell surface that recognize 
gp82 and gp90 are not known, some data reinforce they are different since the target 
cell’s interaction motif of both glycoproteins is distinct [26]. It is important to point 
out that these molecules are not present in tissue culture-derived trypomastigotes. At 
this stage, the molecules described as present in the membrane are gp85 (recognizes 
extracellular matrix), Ssp3, shed acute-phase antigen (SAPA) (trans-sialidase (TS)), 
oligopeptidases (serine proteases), and penetrin, which bind to heparin, heparan 
sulfate, and collagen [10].
Expression of a family of GPI-anchored glycoproteins, termed trans-sialidases/
neuraminidases, present mainly on the surface of trypomastigotes is capable of 
modifying the exposure of surface glycoconjugates both in host cells and in the 
parasite itself. T. cruzi trans-sialidases (TS) are “shed” from the parasite membrane 
to the external medium through microvesicles. Microvesicles have a complex 
lipid bilayer and are responsible for carrying several molecules derived from the 
parasite, such as lipids, proteins, and nucleic acids [27–29]. Trypomastigote TS 
protein structure is formed by two major regions: an N-terminal catalytic region 
and a C-terminal region. C-terminal presents 12 amino acids repeated in tandem, 
named SAPA. TS can be active or inactive. Inactive TS are lectin-like proteins and 
are capable to bind SAcs and β-galactose [30]. Active TS are modified sialidases 
which, in addition to cleaving sialic acid, may transfer from sialoglycoconjugates 
of the host cell to β-galactose of T. cruzi glycoconjugates [31]. The TS gene family is 
complex, consisting of fourteen members divided into two groups: one translates 
TS present in stages present in mammalian hosts (trypomastigotes), and another 
translocates TS present in specific vector stages (epimastigotes). Although bio-
chemical studies do not demonstrate the presence of TS at the amastigote stage, 
immunocytochemical assays have shown that TS can indeed be expressed in 
amastigotes [32–34]. Pereira et al. [35] observed that about 20–30% of cultured 
Figure 2. 
Schematic model of molecules involved in T. cruzi-host cell interaction [10].
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trypomastigotes had trans-sialidases/neuraminidases on their surface and these 
parasites were more invasive than the population that did not express the enzyme. 
Expression of trans-sialidases in T. cruzi is directly related to infectivity/virulence 
of the parasite since proteome studies indicate that different strains exhibit sig-
nificantly different amounts of TS and TS-containing microvesicles and that host 
cells incubated with larger quantities containing microvesicles of TS before infec-
tion with trypomastigotes will generate a greater infection [36]. Results regarding 
virulence had already been related to TS expression through the analysis of virulent 
and non-virulent strains by transcriptome. In this work it can be observed that the 
expression of TS-coding genes during the differentiation process from intracel-
lular amastigote to trypomastigote (end of intracellular cycle) is much higher in 
the virulent than in the non-virulent strain. Associated with this the transfection 
of avirulent strain with gene allowing the constitutive expression of TS also makes 
the release of trypomastigotes faster [37]. The TS family also includes members 
that have no enzymatic activity but which may also be involved in recognition 
between the parasite and the host cell, such as gp85 [38]. Todeschini and colleagues 
[39] demonstrated that inactive enzymes of the TS family are sialic acid-binding 
proteins and terminal β-galactopyranose (βGalp) residues. In relation to gp85/trans-
sialidase, San Francisco and colleagues [40] demonstrate that this protein plays a 
fundamental importance in invasion since its depletion causes a decrease in T. cruzi 
virulence. The same type of result was reported by Pascuale et al. [41] since inactive 
TS expression in trypomastigotes of a strain that does not express these TS (iTS 
null) allowed a better invasion and increase of the parasitic load in mice demon-
strating that the inactive form may act alternatively or complementing the active TS 
in pathogenesis.
Sialic acid from the host cells has a crucial importance in intracellular cycle of 
T. cruzi, a parasite that does not have the ability to synthesize sialic acids. This mol-
ecule plays an important role in protecting T. cruzi from lysis by serum factors and 
also acting in interaction with host cell. Mucins and TS function as substrate and 
enzyme, respectively, and sialylated mucins are localized in microdomain regions 
of trypomastigotes [42]. During the interaction process involving macrophages, the 
presence of sialic acid on the surface of trypomastigotes hinders the invasion pro-
cess, since the removal of these residues through the use of neuraminidase or their 
blockage through the use of periodic acid or lectins from Limax flavus or Limulus 
polyphemus increases adhesion and internalization rates. It is possible that the pres-
ence of desialylated parasites in macrophages may increase due to the recognition of 
galactose/N-acetyl galactosamine receptors present on the surface of macrophages 
[15, 16]. In relation to sialic acid present on the surface of macrophages, there 
has been an increase in the entry of trypomastigote forms in cells that expose this 
residue when compared to cells that do not expose galactose [15, 43]. The presence 
of sialic acid on the surface of trypomastigotes does not yet have a fully known 
function though it is believed that sialic acid helps adhesion and penetration into 
non-phagocytic cells [34, 44].
It is currently discussed that any class of molecules exposed on the surface of 
mammalian cells has a great receptor potential for molecules exposed on the surface 
of T. cruzi [19]. Most of the receptor classes have carbohydrates in their composi-
tion, such as galactose, mannose, sialic acid residues [19, 44, 45], and lectin-type 
proteins such as galectins (binding to carbohydrate residues present on the surface 
of the parasite). Pineda et al. [46] described binding data from different human 
galectins (gal-1, gal-3, gal-4, gal-7, and gal-8) to different strains of T. cruzi belong-
ing to the six different strains (DTUs). It has been observed that all galectins bind 
preferentially to the infective stages (amastigotes and trypomastigotes) and that 
many can promote higher rates of adhesion and infection to host cells and higher 
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rates of infection to mice. In relation to galectin-1, it was observed that the presence 
of this glycoprotein in human and murine cardiomyocytes is able to prevent infec-
tion with trypomastigotes, one more data that goes against the modulating role of 
galectin in the process of internalization of trypomastigotes [47].
Galectin-3, a protein abundant in the cytoplasm of epithelial cells and macro-
phages, has also been described as a participant in the immune response and infec-
tion processes (in addition to the recognition process between the host and T. cruzi) 
[48, 49]. In addition, it has also been demonstrated that galectin-3 accumulates 
in both the parasite and phagosome entry regions and in tubules and vesicles that 
would derive from the endosomal system, thus suggesting that this protein is also 
an excellent marker of the lysis process of the PV containing this parasite [50]. The 
absence of galectin-3, in addition to increasing intracellular replication in vitro, is 
able to increase parasitemia in vivo by decreasing the secretion of pro-inflammatory 
cytokines and increasing cardiac fibrosis [51], which confirms the important role of 
this glycoprotein in the pathogenesis of Chagas disease.
In addition to all the molecules already mentioned, they also act as endothelin-1 
receptors and bradykinin receptors. Both are used by trypomastigotes in the invasion 
of cardiovascular cells, being very important in the pathogenesis of Chagas disease 
[52]. Cytokeratin 18, fibronectin, laminin, and integrin are also recognized by Tc-85, 
forming a bridge between the parasite and the host cell [19, 53, 54]. Besides, a novel 
family of T. cruzi surface membrane proteins (designated as TcSMP) was detected in 
parasite surface and plays some role on host cell invasion by T. cruzi [54].
3.  Mechanisms of internalization of Trypanosoma cruzi trypomastigotes 
in host cells
The mechanisms that lead to the internalization of trypomastigotes appear to 
be different when one considers the cell type where the internalization will occur. 
Morphological evidence shows that the parasite invades the host cell by an endo-
cytic process that culminates in the formation of a PV. In cells of the immune system 
such as macrophages, which are specialized in phagocytosis events, we observe that 
the process of internalization occurs in two distinct ways. Dvorak and Schumunis 
[55] initially suggested that trypomastigotes forced the membrane of the host cell 
in an event where there is energy expenditure by the two cells involved. Nogueira 
and Cohn [56] observed the formation of projections on the surface of the host cell, 
which leads to a classical phagocytic process.
In cells considered as nonprofessional phagocytic, such as epithelial cells and 
fibroblasts, there appears to be a process of internalization where the parasite is the 
agent of penetration [33]. This process was confirmed by Martins et al. [57], where it 
was shown that metacyclic trypomastigotes (G and CL strains) require ATP to invade 
nonprofessional phagocytic cells. In these cell types, two different strategies are 
known to be involved in the invasion process and formation of the PV: one dependent 
on lysosomes and another one independent of lysosomes. The lysosomal-dependent 
pathway, first described by Tardieux et al. [58], was well characterized in nonprofes-
sional phagocytic cell lines. Signals triggered by the recognition between T. cruzi 
and the host cell lead to the recruitment of lysosomes to the parasite’s entry site, 
which would actively participate in the invasion process [33]. In addition, lysosome 
exocytosis would depend (1) on the performance of microtubules [8] and (2) on 
the regulation of host cell cytoplasmic Ca2+ levels [15]. This process of lysosomal-
dependent invasion would occur in about 20% of the parasites [59]. The fusion of the 
lysosomes with the plasma membrane would thus end up donating the membrane 
7How Does the Main Infective Stage of T. cruzi Enter and Avoid Degradation in Host Cells?…
DOI: http://dx.doi.org/10.5772/intechopen.86046
for the formation of the PV in a calcium-dependent process. In addition, a similar 
Ca2+-dependent lysosomal exocytosis mechanism was observed during injury and 
repair of the plasma membrane [60]. Tam et al. [61] demonstrated that the mecha-
nism of injury-dependent endocytosis is directly related to the secretion of a specific 
lysosomal enzyme and acid sphingomyelinase (ASM). ASM would cleave sphingo-
myelin, an abundant sphingolipid in the outer leaflet of the plasma membrane [62], 
forming ceramide, which is internalized by the cell [63–65]. Trypomastigotes are 
able to take advantage of this mechanism by inducing the formation of these vesicles 
rich in ceramides, thus facilitating the invasion process [66]. Over the years, this 
entry mechanism involving plasma membrane repair pathways has been extensively 
studied by several groups. The participation of lysosomal proteins known as Lamp1 
and Lamp2 has been shown to be essential, since the knockout of both proteins 
decreases the entry of trypomastigotes. This decrease in entry is not accompanied by 
inhibition of lysosome exocytosis to the repair region as well as phenotypic modifica-
tion of the host cell or generated PV. It is believed that the decrease in parasite entry 
is due to problems in caveolin-mediated endocytosis and in calcium efflux [67]. 
Considering that there are two distinct pools of lysosomes (cortical and internal) in 
mammalian cells, Hissa and Andrade used cardiomyocytes and observed, through 
the use of specific inhibitors, that trypomastigotes enter into this cell type mainly 
recruiting lysosomes from the more internal cell layer (perinuclear) [52]. Some 
molecules known as SAPs are secreted by microvesicles which are recognized by host 
cells and promote an efflux of perinuclear lysosomes. These molecules probably act 
together with gp82, activating Ca2+ pathway and promoting T. cruzi internalization 
[68]. Another molecule capable to recruit lysosomes to entry site is oligopeptidase also 
involved in Ca2+ efflux [69]. Using non-phagocytic cells it is described that the entry 
of metacyclic trypomastigotes is predominantly due to recruitment of lysosomes, 
whereas entry of cultured trypomastigotes (from the same CL strain) does not 
involve the participation of lysosomes [70]. Recently, Rodrigues et al. [26] observed 
that infection of host cells by metacyclic trypomastigotes is associated with lysosome 
spreading and presence of gp90 (metacyclic trypomastigote surface glycoprotein). 
Strains expressing low amount of surface gp90 are able to recruit more lysosomes to 
the site of infection giving rise to a more successful infection.
In all other mechanisms used by the parasites, there would be no recruit-
ment and exocytosis of lysosomes to the entry site, which are classified as 
lysosomal-independent mechanisms. In these pathways, there is an invagination 
of the plasma membrane of the host cell with the consequent formation of a PV 
without the initial presence of lysosomal markers. In 2002, Wilkowsky et al. 
[14] demonstrated the existence of this lysosomal-independent pathway for the 
invasion of T. cruzi into two nonprofessional phagocytic cell lines. Using Hela 
and CHO cells transfected with Rab5, Rab7, or dinamine-GFP, the presence of 
these endosomal markers in the newly formed vacuole was observed, indicat-
ing that some vacuoles fuse first with early and late endosomes and not with 
lysosomes. Later these events were quantified, and 50% of the parasitophorous 
vacuoles formed used the plasma membrane of the host cell but were enriched 
with PI3-kinase action products and negative for endosomal markers; 20% of 
the other trypomastigote-containing vacuoles were positive for EEA-1 (Rab5 
effector and marker of initial endosomes) and Rab5, and approximately 20% of 
the vacuoles were positive for LAMP-1 (lysosomal marker). Vacuoles from these 
pathways are matured by the gradual fusion of early endosomes as well as of 
lysosomes, which allows the complete formation of the PV [16, 19, 71].  
Both models of interaction are illustrated in Figure 3. In addition to the endoly-
sosomal system, the cytoskeleton and autophagic processes were also related to 
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the complex formation process of T. cruzi parasitophorous vacuoles, but there is still 
much controversy about these involvements. The first time that a compound known 
to interfere with actin polymerization inhibitor was used with the aim of study-
ing the entry of T cruzi was reported by Nogueira and Cohn [56]. Subsequently, 
Meirelles et al. [72] using the same compound demonstrated that the  
treatment of chicken macrophages with cytochalasin prevented the entry of  
the parasite without, however, preventing adhesion. This work was the  
first to split the entry’s phase of T. cruzi (adhesion and internalization). On 
the other hand, using another cytochalasin (cytochalasin D—an actin filament 
polymerization inhibitor) as a tool, it was observed that the infection rate of the 
parasite was not significantly altered [33]. Subsequently the Tardieux group [58] 
demonstrated that invasion of T. cruzi into nonprofessional phagocytic cells is sig-
nificantly enhanced by the depolymerization of the host cell actin cytoskeleton. 
The rapid reorganization of actin occurs as a response to the trypomastigote stage, 
suggesting that the direct reorganization of the actin cytoskeleton is a critical step 
for the entry process [18]. The reduction in the entry process was again observed 
in other studies, indicating that this divergence may be related to the observed 
interaction time [73].
In relation to the microtubules, their dynamics are important to facilitate T. cruzi 
invasion targeting lysosomes to entry site [57, 74]. It is also believed that the PV acts 
as a secondary center for the organization of microtubules, as regards the lysosomal 
fusion process at the parasite’s entry site [74]. Besides a protein known as a CLASP1 
(a microtubule plus-end tracking protein) is described as involved in the internal-
ization of T. cruzi integrating actin pathway with microtubules and helping with the 
perinuclear localization of PV [75]. Microtubules are also responsible for carrying 
vesicles such as those positive for Vamp7 (essential for lysosomal fusion and reten-
tion of infection) to the entry site. This transport is dependent on the KIF 5 protein 
(a kinesin) [76]. More recently, Romano et al. [77] have shown that an autophagic 
protein, LC3, would also be present in the PV membrane, also demonstrating that 
the induction of autophagy in the host cell (pharmacological or physiological) 
interferes with the mechanism of trypomastigote invasion. Autophagy mechanism 
also plays a protective role against T. cruzi infection in mice by activation of a host 
immune response [78].
Figure 3. 
Schematic model of T. cruzi internalization and parasitophorous vacuole formation using different entry 
pathways [10].
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4. Endocytic mechanisms involved in trypomastigote infection
Many processes are already described as involved in the entry of T. cruzi trypomas-
tigotes. As already discussed in this topic since 1972, Dvorak and Schumunis [55] had 
already described that the internalization of trypomastigotes in host cells could be by 
endocytic mechanisms. Endocytic processes are currently divided into different classes: 
clathrin-mediated endocytosis, endocytosis mediated by membrane microdomains (pla-
nar and caveolae), macropinocytosis, and phagocytosis. The first endocytic mechanism 
described as a participant in T. cruzi entry into host cells was phagocytosis. The participa-
tion of this mechanism was described by Nogueira and Cohn [56] through the treatment 
of several cell types, peritoneal macrophages, L929, HeLa, and embryo fibroblasts of 
calves with cytochalasin B (a drug that interferes with the extension of actin filaments). 
Afterward, Barbosa et al. [79] demonstrated by transmission electron microscopy that 
trypomastigotes are able to bind to cardiac muscle cells and induce the formation of 
extensive pseudopodia, a typical feature of phagocytic processes. Subsequently several 
reports showed that actin filaments are essential in other endocytic mechanisms, such as 
the macropinocytosis. Cytochalasins B and D are quite specific inhibitors of phagocytic 
activity. When the parasite is internalized via phagocytosis, there is internalization of 
CR3 receptors, β1 integrin, lysosomal membrane glycoproteins (Lpg), and Fc receptors 
(the latter appears only when trypomastigotes are opsonized). The participation of 
toll-2 receptors (“toll-like receptors 2”), as well as membrane components containing 
galactosyl, sialoconjugate, and glycoconjugate residues [80–82], is also demonstrated. 
In general phagocytosis is also a process that can be divided into different subtypes that 
are morphologically distinct. Using scanning electron microscopy, it was demonstrated 
that during internalization of trypomastigotes, the plasma membrane of peritoneal 
macrophages can cover the parasite in a juxtaposed way, with bilateral projections of 
plasma membrane forming a funnel-like structure that can follow the entire extent of 
the parasite’s body, culminating in its total internalization (similar to what is described 
as classical phagocytosis). It has also been observed in the development of structures 
similar to the initial stages of trigger phagocytosis or macropinocytosis, in addition to the 
formation of structures described as coiled-type phagocytosis [19, 82, 83].
The participation of membrane rafts in the invasion of T. cruzi has also been dem-
onstrated [84, 85]. Regions of membrane microdomains (rafts) are small, dynamic, 
cholesterol-rich membrane invagination regions, where sphingolipids, GM1 gan-
gliosides, and caveolae (caveolae are a special type of membrane rafts) concentrate. 
These regions are known as signaling hotspots because they contain several proteins 
that can be deposited by triggering signaling cascades. This topic (signaling activation 
in T. cruzi entry process) will be discussed later in this chapter. More recently it has 
been demonstrated that T. cruzi could also use another endocytic mechanism in the 
invasion of its host cell: macropinocytosis. [86]. This endocytic pathway involves the 
internalization of large areas of plasma membrane along with significant amounts of 
extracellular fluid. It is important to point out the participation of dynamin as a key 
protein for the formation and consequent release of the early PV from the plasma 
membrane. Its inhibition using dynasore or its blockage through an overexpression of 
a dominant-negative mutant of dynamin inhibits the internalization of trypomasti-
gotes, demonstrating that GTPase activity is also important [71, 86].
5. Signaling pathways involved in trypomastigote penetration
There are several external factors that can regulate different types of cellular 
responses. For these responses to occur, it is necessary that a conformational 
change of several proteins takes place, which means that they can now interact 
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with other molecules leading to their activation, transducing the signal and ampli-
fying it. The conformational change is usually dependent on the action of protein 
kinases or protein phosphatases. The case of the process of interaction between 
Trypanosoma cruzi and host cells is not different since it is also an external process 
that will require an internal response. From this perspective, several studies have 
focused on the investigation of different pathways that coordinate the invasion of 
T. cruzi and that modulate the gene expression of the host cell in response to this 
process [85, 86].
T. cruzi seems to exploit an infinity of cell surface receptors, secondary mes-
sengers, and transcription factors of different pathways to ensure its invasion and 
survival [86–89]. Among the signaling events, the best studied is that which leads 
to a calcium release in the host cells. This calcium release is one of the main respon-
sible for regulating the process of invasion of T. cruzi [9, 18]. Three different models 
have already been proposed by different groups as being responsible for the activa-
tion of this signaling pathway. Among the described models, two involve peptidases 
such as oligopeptidase B and cruzipain, and the third one involves a membrane 
glycoprotein called gp82. Although all three mechanisms activate calcium firing, 
none of them are correlated. The first proposed model is based on the activation of 
the serine peptidase called oligopeptidase B where this enzyme present in the trypo-
mastigote cytosol cleaves an inactive precursor to generate an active calcium agonist 
that is released by the parasite and binds to the receptor present on the surface of 
the host cell. This receptor is coupled to G protein which stimulates phospholipase C 
activity generating inositol 3,4,5-trisphosphate which binds to its receptor releasing 
calcium [90]. The second mechanism, proposed by Scharfstein et al. [91], is based 
on the secretion of cruzipain through the flagellar pocket region. This protein binds 
to a kininogen molecule that is cleaved into short kinin molecules, which in turn 
bind to the bradykinin receptor by stimulating the release of calcium from IP3. 
Cruzipain is also capable to regulate arginase activity increasing T. cruzi survival 
inside the cell through an increase in the production of IL-10 and TGF-β [92]. The 
model based on the activation of the glycoprotein gp82 is known to be bidirectional 
since it has been shown that a peak of calcium is generated not only in the host cell 
but also in the parasite itself. In the case of activation from this glycoprotein, the 
receptor is not yet known [90].
As previously described one of the activated pathways is TGF-β, where mol-
ecules secreted by trypomastigotes stimulate TGF-β receptors and activate the 
transcription of genes regulated by this molecule [93]. Activation of this pathway is 
involved in Chagas disease fibrosis development [94–96]. TGF-β was first described 
as being activated through cruzipain, but it is now known that trypomastigotes are 
capable of exposing phosphatidylserine to the outer layer of the plasma membrane. 
This exposure would be responsible for triggering the TGF signaling pathway in 
macrophages, based on the phosphorylated Smad2 nuclear translocation, leading 
to inhibition of iNOS in infected macrophages. This event would favor intracel-
lular survival of the parasite [97]. More recently, the mechanism used to favor this 
intracellular survival was proposal by Calvet and colleagues [98] using cardio-
myocytes as host cell model. In these cells the TGF-β receptor (TβRII) is localized 
in cardiomyocyte’s costameres, which are also rich in vinculin and associated with 
cytoskeleton (known as a signaling domain). Its activation potentiates Smad2 
phosphorylation. When T. cruzi infection is established, the cytoskeleton is disorga-
nized, disrupting TβRII striations and decreasing Smad2 phosphorylation making 
cardiomyocytes less responsive to exogenous TGF-β stimulation.
Phosphorylation of protein tyrosine kinases is an important step in the regu-
lation of a variety of eukaryotic cell signaling pathways [99]. In professional 
phagocytes, the entry of T. cruzi into macrophages is inhibited by treatment with 
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genistein, a tyrosine kinase inhibitor [79]. It has also been shown that trypomas-
tigotes of the Y strain stimulate tyrosine phosphorylation of a large number of 
proteins [100]. Pretreatment of fibroblasts with genistein does not inhibit entry of 
the parasite [18], suggesting different roles for protein tyrosine kinases in T. cruzi 
invasion of the Y strain in professional phagocytic cells or nonprofessional phago-
cytic cells. In cardiomyocytes and cardiac fibroblasts, tyrosine kinases appear to be 
essential to infection. Tyrosine kinase C (TrkC) is recognized by T. cruzi parasite-
derived neurotrophic factor (PDNF) through neurotrophin receptor culminating in 
the entry of trypomastigotes into cardiac cells, while TrkA activation by the same 
ligand in the same cell types leads to a decrease in oxidative stress [101]. In this same 
sense of protection from the T. cruzi infection, other signaling pathways are also 
activated as, for example, the pathways of Erk11/Erk2 and Jak/STATs [102]. Other 
protein kinases also participate in T. cruzi invasion in host cells, such as protein 
kinase C (PKC), MAP kinases, and phosphatidylinositol 3-kinases (PI3-K) [86, 88, 
97]. Recently the regions known as membrane microdomains have been described 
as signaling platforms. These regions are capable of recruiting a wide range of 
proteins involved in signal transduction processes. These proteins may include tyro-
sine kinase receptors and protein kinases such as PI3 kinase, protein kinase C, Src 
kinase (Lyn and Fyn) family proteins, FAK, bradykinin receptors, GTP (Rac, Rho, 
and Ras), and adapter proteins (Vav, Sos, and Shc). Some of these molecules have 
already had their share in the process of invasion of T. cruzi elucidated, while others 
have not. Proteins such as those from the Src kinases family (responsible for ITAM 
phosphorylation, which is essential for initiating the signal transduction cascade 
that triggers pathogen growth) and adapter proteins such as Vav, although not dem-
onstrated as participants in this process, have been described by Vieira et al. [88] 
as possible phosphorylated proteins during the T. cruzi invasion in macrophages. 
Signaling pathways described as involved in macropinocytosis pathway (Pak1 and 
PKC pathways) are important to the intracellular development of infection [19]. 
More recently, Wnt signaling also has been shown to be an important pathway to 
immunomodulatory functions during T. cruzi infection, regulating the control of 
parasite replication. Activation of Wnt pathway is important to avoid a produc-
tion of pro-inflammatory cytokines and indoleamine 2,3-dioxygenase activity by 
T. cruzi, helping to control the infection [103].
6. Organelles involved in parasitophorous vacuole formation
After the internalization process, T. cruzi resides obligatorily, and temporarily, 
inside a parasitophorous vacuole [10]. Over the years, several groups have described 
that the formation of the vacuole membrane is a complex process related to the par-
ticipation of numerous molecules, depending also on the type of host cell involved 
in the process, i.e., phagocytic lines or nonprofessional phagocytic lines. As regards 
the formation of the PV membrane, it has been previously discussed in this text 
that several components of the host cell have already been described as compo-
nents of the cytoskeleton [19, 73, 104, 105]. The organelle known as endoplasmic 
reticulum (ER) has been described in the literature as a donor membrane for 
phagosome formation, binding directly to the base of this phagosome in formation 
[106]. Recently, our group demonstrated by electron tomography (followed by 3-D 
reconstruction) and fluorescence videomicroscopy that the endoplasmic reticulum 
(ER) participates in the process of formation of the vacuole from initial moments 
until its complete maturation. The participation or not of ER in this process may 
be directly related to the input mechanism used by the parasite at the time of the 
invasion [104].
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The Golgi complex (CG) plays a central role in eukaryotic cells, serving as an 
intermediary and bidirectional axis of protein and lipid trafficking in the endo-
membrane system [107]. In the case of T. cruzi, Carvalho et al. [82] described that 
after long infection times, there would be no change in GC distribution, remaining 
in the perinuclear region. Recently, transmission electron microscopy showed an 
intimate proximity between the CG and the parasite-containing vacuole. These data 
are of extreme relevance due to the function of GC in eukaryotic cells, i.e., because 
the membrane of the PV containing the parasite is still in the process of formation, 
requiring lipids and proteins from the host cell that would aid its closure as well as 
its expansion. As regards mitochondria, apparently there is no direct link between 
this organelle and the vacuole [104].
7.  Disorganization of the parasitophorous vacuole and the 
endolysosomal system
As discussed above trypomastigotes of T. cruzi use different molecules and 
mechanisms to invade a host cell. Regardless of the chosen mechanism (participa-
tion of plasma membrane components or lysosomes at the site of invasion), the 
parasite will be located inside a vacuole.
Inside the PV the trypomastigotes release the enzyme trans-sialidase/neur-
aminidase, which is responsible for the removal of the sialic acid residues from 
the vacuole membrane. This removal makes it sensitive to the action of another 
enzyme, homologous to factor 9 of human complement, Tc-Tox. The lysis of the 
vacuole membrane by the action of Tc-Tox may be associated with the formation of 
pores in this membrane, which, together with the secretion by the trans-sialidase/
neuraminidase parasite, will lead to the complete fragmentation of the PV mem-
brane [35, 108].
Despite the attempt to determine the exact moment of the T. cruzi exit process 
from the parasitophorous vacuole, this step has not yet been well elucidated. Since 
1989, however, our group has been trying to chart the paths necessary for this 
discovery. Initially Carvalho and De Souza [109] demonstrated by transmission 
electron microscopy that the lysing process of the PV membrane begins to occur 
in the first 2 hours of interaction of the trypomastigote stage in peritoneal mac-
rophages, already suggesting the occurrence of fusion of lysosomes, after entry 
of the parasites. More recently, Reignault and colleagues [50] demonstrate that 
galectin-3 decorates T. cruzi vacuole acting as an important marker to be used also 
for the study of parasitic vacuole lysis of T. cruzi, as it also undergoes a process of 
disorganization with consequent exit of the parasite into the cytoplasm of the host 
cell. Transcriptome studies have shown an extensive remodeling of the intracellular 
T. cruzi in the first 4 hours of trypomastigote invasion (until the parasitophorous 
vacuole disintegration), and these modifications can be associated with a regulation 
of the initial step of host cell invasion [110]. Some modifications occurring in intra-
cellular differentiation processes (trypomastigotes to amastigotes and subsequently 
to trypomastigotes again) may be involved in the process of destruction of PV. One 
of the modifications that seems to be involved with this process is the increase in 
the enzymatic activity of glutamine synthase during the amastigogenesis process. 
This enzyme is normally involved in the process of handling excess ammonia, and 
given the fact that the main energy source of the intracellular forms of T. cruzi is 
from amino acids, the ammonium generation is high. Marim et al. [111] observed 
that the activity blockage of this enzyme impair the progression of the intracel-
lular cycle (amastigotes did not differentiate for trypomastigotes). In this case the 
role of the enzyme is to regulate the intracellular pH by controlling the content of 
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intravacuolar ammonium (generated by the consumption of amino acids in this 
reduced space). It is this acidification process followed by the pH control that allows 
the enzymatic activity that culminates in the release of parasite in the cytoplasmic 
environment allowing the infection to continue [112].
8. Concluding remarks
Host cell invasion and parasite internalization are important steps in the 
evolution of parasitism by several pathogens. These processes present at least two 
important advantages: protection against the host immune response and access to a 
microenvironment rich in metabolic products. Substantial progress has been made 
in understanding the roles of proteins in infection and invasion by T. cruzi. Host cell 
intracellular signaling can combat the infection; but it can also favor parasite entry. 
Parasites hijack the host immune response, phagocytosis, ECM, and antiparasitic 
proteins for their own survival, replication, and immune evasion purposes. The 
complex networks are interconnected and require extensive study to identify intra-
cellular rearrangements that facilitate parasite internalization. A multidisciplinary 
approach is necessary to a better understanding of parasite-host interaction and 
will be critical to better understand Chagas disease physiopathology, diagnosis, and 
treatment.
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